Evidence map›Paper›PMID 33961653›Full record

ArticlePloS one2021

Attitudes and perceptions of next-of-kin/loved ones toward end-of-life HIV cure-related research: A qualitative focus group study in Southern California.

Sogol S Javadi, Kushagra Mathur, Susanna Concha-Garcia, Hursch Patel, Kelly E Perry, Megan Lo, Jeff Taylor, Andy Kaytes, Susan Little, Sara Gianella and 2 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 15 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Sogol S JavadiAntiViral Research Center, University of California San Diego, San Diego, CA, United States of America.ORCID 0000-0002-2366-4550
Kushagra MathurAntiViral Research Center, University of California San Diego, San Diego, CA, United States of America.
Susanna Concha-GarciaAntiViral Research Center, University of California San Diego, San Diego, CA, United States of America.
Hursch PatelUNC Gillings School of Global Public Health, Chapel Hill, NC, United States of America.ORCID 0000-0002-0725-4922
Kelly E PerryUNC Gillings School of Global Public Health, Chapel Hill, NC, United States of America.ORCID 0000-0002-8637-4729
Megan LoAntiViral Research Center, University of California San Diego, San Diego, CA, United States of America.
Jeff TaylorAntiViral Research Center Community Advisory Board, San Diego, CA, United States of America.
Andy KaytesAntiViral Research Center Community Advisory Board, San Diego, CA, United States of America.
Susan LittleAntiViral Research Center, University of California San Diego, San Diego, CA, United States of America.ORCID 0000-0002-7645-9737
Sara GianellaAntiViral Research Center, University of California San Diego, San Diego, CA, United States of America.
Davey SmithAntiViral Research Center, University of California San Diego, San Diego, CA, United States of America.
Karine DubéUNC Gillings School of Global Public Health, Chapel Hill, NC, United States of America.
University of California San Diego · USDesert AIDS Project · US

Funding

VirologyP30AI036214 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SUSAN JANET LITTLE · 1994 to 2026
$78.4M
STRUCTURAL NEUROIMAGING COREP30MH062512 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Jessica Lynette Montoya · 2001 to 2026
$50.4M
California NeuroAIDS Tissue NetworkU24MH100928 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ACHIM, CRISTIAN L, MOORE, DAVID J · 2013 to 2023
$13.9M
Revealing Reservoirs during Rebound (R3)P01AI131385 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SMITH, DAVID MITCHELL · 2017 to 2021
$8.7M
Training Program for Scientists Conducting Research to Reduce HIV Health DisparitR25MH067127 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Emily A Arnold, Torsten Brian Neilands · 2003 to 2026
$5.4M
High-throughput Deep Sequencing Assay to Reliably Measure the HIV Reservoir during Antiretroviral TherapyR01AI120009 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SMITH, DAVID MITCHELL · 2015 to 2019
$3.4M
Mentoring Translational Research in HIVK24AI100665 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI SMITH, DAVID MITCHELL · 2012 to 2021
$1.5M
Pilot Integration of Participant-Centered Outcomes in HIV Cure Research in the United States: Implications for Ethical ConductR21MH118120 · NIMH · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DUBE, KARINE · 2019 to 2020
$566k
Effect of Declining Sex Hormones on HIV persistence in HIV Infected Women on ARTR21HD094646 · NICHD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GIANELLA WEIBEL, SARA · 2017 to 2018
$441k
Effect of Sex Hormones on HIV persistenceR21AI134295 · NIAID · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GIANELLA WEIBEL, SARA · 2017 to 2018
$426k
NIAID NIH HHS K24 AI100665NIAID NIH HHS P01 AI131385NIAID NIH HHS P30 AI036214NIAID NIH HHS R01 AI120009NIAID NIH HHS R21 AI134295NICHD NIH HHS R21 HD094646NIMH NIH HHS P30 MH062512NIMH NIH HHS R21 MH118120NIMH NIH HHS R25 MH067127NIMH NIH HHS U24 MH100928
6 · The paper itself

Abstract

As end-of-life (EOL) HIV cure-related research expands, understanding perspectives of participants' next-of-kin (NOK) is critical to maintaining ethical study conduct. We conducted two small focus groups and two one-on-one interviews using focus group guides with the NOK of Last Gift study participants at the University of California, San Diego (UCSD). Participating NOK included six individuals (n = 5 male and n = 1 female), including a grandmother, grandfather, partner, spouse, and two close friends. Researchers double-coded the transcripts manually for overarching themes and sub-themes using an inductive approach. We identified six key themes: 1) NOK had an accurate, positive understanding of the Last Gift clinical study; 2) NOK felt the study was conducted ethically; 3) Perceived benefits for NOK included support navigating the dying/grieving process and personal growth; 4) Perceived drawbacks included increased sadness, emotional stress, conflicted wishes between NOK and study participants, and concerns around potential invasiveness of study procedures at the EOL; 5) NOK expressed pride in loved ones' altruism; and 6) NOK provided suggestions to improve the Last Gift study, including better communication between staff and themselves. These findings provide a framework for ethical implementation of future EOL HIV cure-related research involving NOK.

Indexed as

AttitudeDeathFamilyHIV InfectionsCaliforniaFemaleFocus GroupsHumansMaleQualitative ResearchTerminal Care

Identifiers

PMID33961653
PMCPMC8104928
OpenAlexW3157689208

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.